Vote for your favorite mineral in #MinCup25! - Silver vs. Baryte
Are you ready for beautiful utility as sparkling silver competes against hefty baryte?
Log InRegister
Quick Links : The Mindat ManualThe Rock H. Currier Digital LibraryMindat Newsletter [Free Download]
Home PageAbout MindatThe Mindat ManualHistory of MindatCopyright StatusWho We AreContact UsAdvertise on Mindat
Donate to MindatCorporate SponsorshipSponsor a PageSponsored PagesMindat AdvertisersAdvertise on Mindat
Learning CenterWhat is a mineral?The most common minerals on earthInformation for EducatorsMindat ArticlesThe ElementsThe Rock H. Currier Digital LibraryGeologic Time
Minerals by PropertiesMinerals by ChemistryAdvanced Locality SearchRandom MineralRandom LocalitySearch by minIDLocalities Near MeSearch ArticlesSearch GlossaryMore Search Options
Search For:
Mineral Name:
Locality Name:
Keyword(s):
 
The Mindat ManualAdd a New PhotoRate PhotosLocality Edit ReportCoordinate Completion ReportAdd Glossary Item
Mining CompaniesStatisticsUsersMineral MuseumsClubs & OrganizationsMineral Shows & EventsThe Mindat DirectoryDevice SettingsThe Mineral Quiz
Photo SearchPhoto GalleriesSearch by ColorNew Photos TodayNew Photos YesterdayMembers' Photo GalleriesPast Photo of the Day GalleryPhotography

(2020) Adalimumab/infliximab. Reactions Weekly, 1791 (1) 17 doi:10.1007/s40278-020-74862-4

Advanced
   -   Only viewable:
Reference TypeJournal (article/letter/editorial)
TitleAdalimumab/infliximab
JournalReactions Weekly
Year2020 (February)Volume1791
Issue1
PublisherSpringer Science and Business Media LLC
DOIdoi:10.1007/s40278-020-74862-4Search in ResearchGate
Generate Citation Formats
Mindat Ref. ID13397130Long-form Identifiermindat:1:5:13397130:1
GUID0
Full Reference(2020) Adalimumab/infliximab. Reactions Weekly, 1791 (1) 17 doi:10.1007/s40278-020-74862-4
Plain Text(2020) Adalimumab/infliximab. Reactions Weekly, 1791 (1) 17 doi:10.1007/s40278-020-74862-4
In(2020, February) Reactions Weekly Vol. 1791 (1) Springer Science and Business Media LLC

See Also

These are possibly similar items as determined by title/reference text matching only.

(2020) Adalimumab/infliximab. Reactions Weekly, 1825 (1) 17 doi:10.1007/s40278-020-84257-0
(2020) Adalimumab/infliximab. Reactions Weekly, 1790 (1) 17 doi:10.1007/s40278-020-74636-y
(2020) Adalimumab/infliximab. Reactions Weekly, 1811 (1) 17 doi:10.1007/s40278-020-80240-0
(2020) Adalimumab/etanercept/infliximab. Reactions Weekly, 1803 (1) 17 doi:10.1007/s40278-020-78211-9
(2020) Adalimumab/azathioprine/infliximab. Reactions Weekly, 1800 (1) 15 doi:10.1007/s40278-020-77377-4
(2020) Adalimumab/prednisolone/unspecified steroids. Reactions Weekly, 1791 (1) 18 doi:10.1007/s40278-020-74863-4
(2020) Infliximab. Reactions Weekly, 1791 (1) 140 doi:10.1007/s40278-020-74985-0
(2020) Infliximab. Reactions Weekly, 1791 (1) 141 doi:10.1007/s40278-020-74986-0
(2020) Adalimumab/infliximab. Reactions Weekly, 1829 (1) 20 doi:10.1007/s40278-020-85610-6
(2020) Adalimumab/infliximab. Reactions Weekly, 1829 (1) 21 doi:10.1007/s40278-020-85611-6
(2020) Adalimumab/Infliximab. Reactions Weekly, 1785 (1) 22 doi:10.1007/s40278-020-73003-3
 
and/or  
Mindat.org is an outreach project of the Hudson Institute of Mineralogy, a 501(c)(3) not-for-profit organization.
Copyright © mindat.org and the Hudson Institute of Mineralogy 1993-2025, except where stated. Most political location boundaries are Β© OpenStreetMap contributors. Mindat.org relies on the contributions of thousands of members and supporters. Founded in 2000 by Jolyon Ralph.
To cite: Ralph, J., Von Bargen, D., Martynov, P., Zhang, J., Que, X., Prabhu, A., Morrison, S. M., Li, W., Chen, W., & Ma, X. (2025). Mindat.org: The open access mineralogy database to accelerate data-intensive geoscience research. American Mineralogist, 110(6), 833–844. doi:10.2138/am-2024-9486.
Privacy Policy - Terms & Conditions - Contact Us / DMCA issues - Report a bug/vulnerability Current server date and time: September 5, 2025 07:38:02
Go to top of page